Brownie's Marine Group, Inc 10-Q

ITEM 1. FINANCIAL STATEMENTS BROWNIE’S MARINE GROUP, INC. AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS June 30, 2026 December 31, 2025 (Unaudited) ASSETS Current Assets Cash $ 714,411 $ 307,886 Accounts receivable – net of allowances of $ 30,061 at June 30, 2026 and $ 20,552 at December 31, 2025 505,267 189,431 Accounts receivable - related parties 55,659 20,492 Accounts receivable 55,659 20,492 Inventory, net 2,364,190 2,339,931 Prepaid expenses and other current assets 365,939 182,373 Total current assets 4,005,466 3,040,113 Property, equipment and leasehold improvements, net 237,786 237,835 Operating lease right-of-use assets 965,699 1,200,507 Intangible assets, net 404,866 441,099 Goodwill 249,986 249,986 Other assets 45,177 51,826 Total assets $ 5,908,980 $ 5,221,366 Liabilities and stockholders’ equity Current liabilities Accounts payable and accrued liabilities $ 823,492 $ 585,531 Accounts payable - related parties 28,081 12,972 Customer deposits and unearned revenue 199,041 156,036 Other liabilities 144,264 157,188 Operating lease liabilities 517,838 484,078 Related party convertible demand note, net 29,717 29,717 Convertible notes 357,624 355,543 Current maturities long term debt 1,223 174,975 Related party notes payable 505,000 505,000 Total current liabilities $ 2,606,279 $ 2,461,040 Loans payable, net of current portion 76,566 31,197 Operating lease liabilities 518,173 794,857 Total liabilities $ 3,201,018 $ 3,287,094 Commitments and contingent liabilities (see note 8) - - Stockholders’ equity Preferred stock; $ 0.001 par value: 10,000,000 shares authorized; 425,000 issued and outstanding as of June 30, 2026 and December 31, 2025. 425 425 Common stock; $ 0.0001 par value; 1,000,000,000 shares authorized; 512,866,229 shares issued and outstanding at June 30, 2026 and 449,430,935 shares issued and outstanding at December 31, 2025. 51,288 50,328 Common stock payable 138,941 shares as of June 30, 2026 and December 31, 2025. 14 14 Additional paid-in capital 19,975,903 19,914,863 Accumulated deficit ( 17,319,669 ) ( 18,031,358 ) Total stockholders’ equity $ 2,707,960 $ 1,934,272 Total liabilities and stockholders’ equity $ 5,908,980 $ 5,221,366 The accompanying condensed notes are an integral part of these unaudited consolidated financial statements 4 BROWNIE’S MARINE GROUP, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENT OF OPERATIONS (unaudited) 2026 2025 2026 2025 Three months ended June 30, Six months ended June 30, 2026 2025 2026 2025 Revenues Revenues $ 1,700,210 $ 2,455,471 $ 4,155,681 $ 3,775,476 Revenues - related parties 274,035 63,419 337,454 272,617 Revenues 274,035 63,419 337,454 272,617 Total Revenues 1,974,245 2,518,890 4,493,135 4,048,093 Cost of revenues Cost of revenues 523,406 1,559,197 2,082,603 2,482,484 Cost of revenues - related parties 72,061 40,222 112,283 112,486 Cost of revenues 72,061 40,222 112,283 112,486 Royalties expense - related parties 14,284 11,925 26,209 15,917 Royalties expense 45,252 22,688 67,940 48,317 Total cost of revenues 655,003 1,634,032 2,289,035 2,659,204 Gross profit 1,319,242 884,858 2,204,100 1,388,889 Operating expenses Selling, general and administrative 1,463,485 753,990 2,217,475 1,302,116 Research and development costs 6,838 1,505 8,343 2,647 Total operating expenses 1,470,322 755,495 2,225,817 1,304,763 Income (loss) from operations ( 151,080 ) 129,363 ( 21,717 ) 84,126 Other (income) expense, net 851,028 22,438 851,028 22,438 Interest expense ( 119,405 ) 1,783 ( 117,622 ) ( 39,305 ) Income (Loss) before provision for income taxes 580,542 153,584 711,688 67,259 Provision for income taxes - - - - Net Income (Loss) $ 580,542 $ 153,584 $ 711,688 $ 67,259 Basic income (loss) per common share $ 0.00 $ 0.00 $ 0.00 $ 0.00 Basic weighted average common shares outstanding 512,867,229 449,567,461 512,867,229 449,567,462 Diluted income (loss) per common share $ 0.00 $ 0.00 $ ( 0.00 ) $ ( 0.00 ) Diluted weighted average common shares outstanding 512,867,229 449,567,461 512,867,229 449,567,462 The accompanying condensed notes are an integral part of these unaudited consolidated financial statements 5 BROWNIE’S MARINE GROUP, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2026 AND 2025 (unaudited) Shares Amount Shares Amount Shares Amount Capital Deficit Equity Preferred Stock Common Stock Common Stock Payable Additional Paid-in Accumulated Total Stockholder’s Shares Amount Shares Amount Shares Amount Capital Deficit Equity December 31, 2024 425,000 $ 425 449,430,935 $ 44,944 138,941 $ 14 $ 19,460,786 $ ( 17,926,209 ) $ 1,579,960 Shares issued for the purchase of units - - - - - Shares issued for accrued interest on convertible notes - - 276,054 27 - - 13,973 - 14,000 Stock option expense - - - - - - Net Income ( Loss) - - - - - - - 67,259 67,259 Balance June 30, 2025 (unaudited) 425,000 $ 425 449,703,989 $ 44,971 138,941 $ 14 $ 19,474,759 $ ( 17,858,950 ) $ 1,661,219 Preferred Stock Common Stock Common Stock Payable Additional Paid-in Accumulated Total Stockholder’s Shares Amount Shares Amount Shares Amount Capital Deficit Equity December 31, 2025 425,000 $ 425 503,267,154 $ 50,328 138,941 $ 14 $ 19,914,863 $ ( 18,031,358 ) $ 1,934,272 Shares issued for accrued interest on convertible notes - - 273,054 27 - - 13,973 - 14,000 Shares issued for salary reduction 3,023,946 302 16,698 17,000 Shares issued for board compensation 4,740,577 474 20,526 21,000 Shares issued for signing bonus 1,562,500 156 9,844 10,000 Stock option expense - - - - - - - Net Income(loss) - - - - - - - 711,688 711,688 June 30, 2026 (unaudited) 425,000 $ 425 512,867,231 $ 51,288 138,941 $ 14 $ 19,975,903 $ ( 17,319,669 ) $ 2,707,960 The accompanying condensed notes are an integral part of these unaudited consolidated financial statements 6 BROWNIE’S MARINE GROUP, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENT OF CASH FLOWS FOR THE THREE MONTHS ENDED JUNE 30, (unaudited) 2026 2025 Cash flows from operating activities: Net Income $ 711,688 $ 67,259 Adjustments to reconcile net loss to cash used in operating activities: Depreciation and amortization 36,282 60,931 Amortization of debt discount 1,828 Amortization of right-of-use asset 234,808 201,667 Allowance for Nomad recall - Stock Based Compensation - Options - Shares issued for services 62,000 Shares issued for accrued interest on convertible notes 14,000 Changes in operating assets and liabilities Change in accounts receivable, net ( 315,836 ) ( 182,352 ) Change in accounts receivable - related parties ( 35,167 ) ( 16,869 ) Change in inventory ( 24,259 ) ( 163,557 ) Change in prepaid expenses and other current assets ( 183,566 ) 90,323 Change in other assets 6,649 0 Change in accounts payable and accrued liabilities 237,961 78,609 Change in customer deposits and unearned revenue 43,005 ( 148,750 ) Change in long term lease liability ( 242,924 ) ( 186,723 ) Change in other liabilities ( 12,924 ) 219,062 Change in accounts payable - related parties 15,109 441 Net cash provided by operating activities $ 532,827 $ 35,869 Cash flows from investing activities: Purchase of fixed assets - - Net cash used in investing activities - - Cash flows from financing activities: - - Proceeds from issuance of units - - Proceeds of related party demand note Proceeds from notes payable ( 128,383 ) Proceeds of long term debt Repayment on notes payable - - Repayment of debt 2,081 - Net cash used in financing activities $ ( 126,303 ) Net increase (decrease) in cash $ 406,523 $ 35,869 Cash, beginning balance 307,886 417,678 Cash, end of period $ 714,411 $ 453,547 Supplemental disclosures of cash flow information: Cash Paid for Interest $ 103,622 $ 21,299 Cash paid for Operating lease liabilities (included in net cash used in operating activities 773,006 Cash Paid for Income Taxes $ - - Supplemental disclosure of non-cash financing activities: Common Stock issued for payment of convertible note interest - - Shares issued for services 62,000 - Shares issued for convertible note interest 14,000 14,000 Equipment obtained through financing $ - $ - The accompanying condensed notes are an integral part of these unaudited consolidated financial statements 7 BROWNIE’S MARINE GROUP, INC. AND SUBSIDIARIES CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS JUNE 30, 2026 (UNAUDITED) Note 1. Company Overview Brownie’s Marine Group, Inc. (the “Company”) designs, tests, manufactures and distributes recreational hookah diving, scuba, and water safety products through its wholly owned subsidiary, Trebor Industries, Inc., a Florida corporation, incorporated in 1981 (“Trebor” or “BTL”), manufactures and sells high pressure air and industrial compressor packages, yacht based scuba air compressor and nitrox generation systems through its wholly owned subsidiary, Brownie’s High Pressure Compressor Services, Inc., a Florida corporation incorporated in 2017 (“BHP”) and doing business as LW Americas (“LWA”) and develops and markets portable battery powered surface supplied air dive systems through its wholly owned subsidiary BLU3, Inc., a Florida corporation (“BLU3”). On September 3, 2021, the Company, entered into an Agreement and Plan of Merger and Reorganization (the “Merger Agreement”) with Submersible Acquisition, Inc., a Florida corporation and wholly owned subsidiary of the Company (“Acquisition Sub”), Submersible Systems, Inc., a Florida corporation (“Submersible” or “SSI”), and Summit Holdings V, LLC, a Florida limited liability company (“Summit”) and Tierra Vista Group, LLC, a Florida limited liability company (“Tierra Vista” and, together with Summit, the “Sellers”), the owners of all of the capital stock of Submersible, pursuant to which Acquisition Sub merged with and into Submersible (the “Merger”), and Submersible, the surviving corporation, became a wholly owned subsidiary of the Company. Submersible is a manufacturer of high pressure tanks and redundant air systems for the military and recreational diving industries, based in Huntington Beach, California and sells its products to governments, militaries, private companies and the dive industry throughout the world. On February 13, 2022 the Company filed with the Florida Department of State, the articles of incorporation for a new wholly owned subsidiary, Live Blue, Inc. (“LBI”). LBI utilizes technology developed by BLU3 to provide new users and interested divers a guided tour experience. On May 2, 2022, the Company entered into an asset purchase agreement (the “Asset Purchase Agreement”) with Gold Coast Scuba, LLC, a Florida limited liability company (“Gold Coast Scuba”), Steven M. Gagas and William Frenier, the sole members of Gold Coast Scuba (together, the “LLC Members”) and LBI. Pursuant to the terms of the Asset Purchase Agreement, LBI acquired substantially all of Gold Coast Scuba’s assets and assumed certain non-material liabilities of the business associated with these assets. In addition, LBI assumed the lease for the premises for Gold Coast Scuba as part of this asset acquisition. Note 2. Basis of Presentation and Summary of Significant Accounting Policies Basis of Presentation The unaudited interim consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Accordingly, such interim financial statements do not include all the information and footnotes required by accounting principles generally accepted in the United States (“GAAP”) for complete annual financial statements. The information furnished reflects all adjustments, consisting only of normal recurring items which are, in the opinion of management, necessary in order to make the financial statements not misleading. The balance sheet as of December 31, 2025 has been derived from the Company’s annual financial statements that were audited by an independent registered public accounting firm but does not include all of the information and footnotes required for complete annual financial statements. These financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto which are included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025 for a broader discussion of the Company’s business and the risks inherent in such business. The results of operations for the six months ended June 30, 2026, are not necessarily indicative of results to be expected for any other interim period or the fiscal year ending December 31, 2026. 8 Principles of Consolidation The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Trebor, BHP, BLU3, SSI and LBI. All significant intercompany transactions and balances have been eliminated in consolidation. Use of estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Cash and cash equivalents Only highly liquid investments with original maturities of 90 days or less are classified as cash and equivalents. These investments are stated at cost, which approximates market value. Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash deposits. Accounts at each institution are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $ 250,000 per EIN. At June 30, 2026 and December 31, 2025, the Company had approximately $ 400,000 and $ 25,000 , respectively, in excess of the FDIC insured limit. Accounts receivable The Company manufactures and sells its products to a broad range of customers, primarily retail stores. Few customers are provided with payment terms of 30 days. The Company has tracked historical loss information for its trade receivables and compiled historical credit loss percentages for different aging categories (current, 1–30 days past due, 31–60 days past due, 61–90 days past due, and more than 90 days past due). In accordance with ASU 2016-13, Financial Instruments-Credit Losses (Topic 326), management believes that the although, the Company had historical loss information, the Company is showing improvements in cash sales and collections of accounts receivable resulting in a decrease of allowance for doubtful accounts. as of June 30, 2026. Although the composition of the trade receivables at that date is consistent with that used in developing the historical credit-loss percentages (i.e., the similar risk characteristics of its customers and its lending practices have not changed significantly over time). Accordingly, the allowance for expected credit losses at June 30, 2026 and December 31, 2025 totaled $ 30,061 and $ 20,552 , respectively. Inventory Inventory consists of the following: Schedule of Inventory June 30, 2026 December 31, 2025 Raw materials $ 1,455,751 $ 1,477,422 Work in process 60,691 60,401 Finished goods 1,004,903 978,527 Rental Equipment - - Allowance excess and obsolete inventory ( 157,156 ) ( 176,419 ) Inventory, net $ 2,364,190 $ 2,339,931 9 Revenue Recognition The Company recognizes revenue in accordance with ASC Topic 606 Revenue from Contracts with Customers . The Company recognizes revenue when performance obligations under the terms of a contract with the customer are satisfied. The Company typically satisfies its performance obligations in contracts with customers upon shipment of the goods. Generally, payment is due upon receipt of the invoice and the contracts do not have significant financing components. Product sales occur once control or title is transferred based on the commercial terms. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods. Product sales are recorded net of variable consideration, such as provisions for returns, discounts and promotional allowances. Such provisions are calculated based on the actual allowances given. Management believes that adequate provision has been made for cash discounts, returns, spoilage and promotional allowances based on the Company’s historical experience. A breakdown of the total revenue between related party and non-related party revenue is as follows: Schedule of related Party and Non-related Party Revenue 2026 2025 Six months ended June 30, 2026 2025 (unaudited) (unaudited) Revenues $ 4,155,681 $ 3,775,476 Revenues - related parties 337,454 272,617 Total Revenues $ 4,493,135 $ 4,048,093 Cost of Sales Cost of sales consists of the cost of the components of finished goods, the costs of raw materials utilized in the manufacture of products, in-bound and out- bound freight charges, direct manufacturing labor as well as certain internal transfer costs, warehouse expenses incurred prior to the manufacture of the Company’s finished products, inventory allowance for excess and obsolete inventory, and royalties paid on licensing agreements. Components account for the largest portion of the cost of sales. Components include plastic molded parts, gas powered engines, aluminum pressure bottles, electronic parts, batteries and packaging materials. The breakdown of cost of sales to include cost of sales for related party and non-related party as well as the related party and non-related party royalty expense is as follows: Schedule of Related Party and Non-related Party Cost of Revenue 2026 2025 Six months ended June 30, 2026 2025 (unaudited) (unaudited) Cost of revenues $ 2,082,603 $ 2,482,484 Cost of revenues - related parties 112,283 112,486 Cost of revenues 112,283 112,486 Royalties expense - related parties 26,209 15,917 Royalties expense 67,940 48,317 Total cost of revenues $ 2,289,035 $ 2,659,204 10 Lease Accounting The Company accounts for leases in accordance with ASC 842, Leases. The lease standard requires all leases to be reported on the balance sheet as right-of-use assets and lease obligations. The Company elected the practical expedients permitted under the transition guidance of the new standard that retained the lease classification and initial direct costs for any leases that existed prior to adoption of the standard. The Company did not reassess whether any contracts entered into prior to adoption are leases or contain leases. The Company categorizes leases with contractual terms longer than twelve months as either operating or finance. Finance leases are generally those leases that would allow the Company to substantially utilize or pay for the entire asset over its estimated life. Assets acquired under finance leases are recorded in property and equipment. All other leases are categorized as operating leases. The Company did not have any finance leases as of June 30, 2026. The Company’s leases generally have terms that range from three years for equipment and five to twenty years for property. The Company elected the accounting policy to include both the lease and non-lease components of its agreements as a single component and account for them as a lease. Operating lease liabilities are recognized at the present value of the fixed lease payments using a discount rate based on similarly secured borrowings available to the Company. Operating lease right-of-use (“ROU”) assets are recognized based on the initial present value of the fixed lease payments, reduced by landlord incentives, plus any direct costs from executing the leases. Operating lease ROU assets are tested for impairment in the same manner as long-lived assets used in operations. Leasehold improvements are capitalized at cost and amortized over the lesser of their expected useful life or the lease term. When the Company has the option to extend the lease term, terminate the lease for the contractual expiration date, or purchase the leased asset, and it is reasonably certain that the Company will exercise the option, it considers these options in determining the classification and measurement of the lease. Costs associated with operating lease assets are recognized on a straight-line basis within operating expenses over the term of the lease. For the six months ended June 30, 2026, and June 30, 2025, cash paid for operating lease liabilities was $ 773,006 and $ 532,966 , respectively. Supplemental balance sheet information related to leases was as follows: Schedule of Supplemental Balance Sheet Information Operating Leases June 30, 2026 (unaudited) Right-of-use assets $ 965,699 Current lease liabilities $ 517,838 Non-current lease liabilities 518,173 Total lease liabilities $ 1,036,012 Stock-Based Compensation The Company accounts for stock-based compensation in accordance with ASC 718, Compensation-Stock Compensation . ASC 718 requires companies to measure the cost of employee and non-employee services received in exchange for an award of equity instruments, including stock options, based on the grant-date fair value of the award and to recognize it as compensation expense over the period the employee and non-employee are required to provide service in exchange for the award, usually the vesting period. The Company uses the Black-Scholes valuation model to calculate the fair value of options and warrants issued to both employees and non-employees. Stock issued for compensation is valued on the effective date of the agreement in accordance with generally accepted accounting principles, which includes determination of the fair value of the share-based transaction. The fair value is determined through use of the quoted stock price. 11 Derivatives The accounting treatment of derivative financial instruments requires that the Company record certain warrants and embedded conversion options at their fair value as of the inception date of the agreement and at fair value as of each subsequent balance sheet date. Any change in fair value is recorded as non-operating, non-cash income or expense for each reporting period at each balance sheet date. If the classification changes as a result of events during the period, the contract is reclassified as of the date of the event that caused the reclassification. As a result of entering into certain note agreements, for which such instruments contained a variable conversion feature with no floor, the Company has adopted a sequencing policy, by earliest issuance date, in accordance with ASC 815-40-35-12 whereby all future instruments may be classified as a derivative liability with the exception of instruments related to share-based compensation issued to employees or directors, as long as the certain variable issuance terms in certain convertible instruments exist. As of June 30, 2026, and December 31, 2025, the Company did not have any derivative liabilities. Loss per share of common stock Basic loss per share excludes any dilutive effects of options, warrants and convertible securities. Basic earnings per share is computed using the weighted- average number of outstanding common shares during the applicable period. Diluted loss per share is computed using the weighted average number of common and dilutive common stock equivalent shares outstanding during the period. Common stock equivalent shares are excluded from the computation if their effect is anti-dilutive. For the six months ended June 30, 2026, 0 shares were included in diluted weighted average common shares outstanding and for the six months ended June 30, 2025, 500,376,419 shares of potentially dilutive shares were not recognized as their inclusion would be anti-dilutive. These shares reflect shares potentially issuable under convertible notes, outstanding warrants, outstanding stock options and the conversion of preferred stock. Recent accounting pronouncements ASU 2016-13 Current Expected Credit Loss (ASC326) In December 2021, the FASB issued an update to ASU No. 2016-13 the Current Expected Credit Losses (CECL) standard (ASC 326), which is designed to provide greater transparency and understanding of credit risk by incorporating estimated, forward-looking data when measuring lifetime Estimated Credit Losses (ECL) and requires enhanced financial statement disclosures. This guidance was adopted on January 1, 2023, with no effect to the financial statements. ASU 2020-06 Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40) - Accounting for Convertible Instruments and Contracts on an Entity’s Own Equity. In August 2020, the FASB issued ASU 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40) - Accounting for Convertible Instruments and Contracts on an Entity’s Own Equity. The ASU simplifies accounting for convertible instruments by removing major separation models required under current GAAP. Consequently, more convertible debt instruments will be reported as a single liability instrument with no separate accounting for embedded conversion features. The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify for the exceptions. The ASU also simplifies the diluted net income per share calculation in certain areas. The new guidance is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, and early adoption is permitted. The Company is currently evaluating the impact of the adoption of the standard on the consolidated financial statements. Other accounting standards that have been issued or proposed by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on our financial statements upon adoption or are not applicable. 12 Note 3. Going Concern The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates realization of assets and the satisfaction of liabilities in the normal course of business for the twelve-month period following the date these consolidated financial statements were issued. For the six months ended June 30, 2026, the Company had a net income of $ 714,174 . At June 30, 2026, the Company had an accumulated deficit of $ 17,319,669 . The Company had a working capital surplus of approximately $ 1,400,227 at June 30, 2026. The historical losses and cash used in operations raise substantial doubt as to the Company’s ability to continue as a going concern. The Company’s ability to continue as a going concern is dependent upon the Company’s ability to increase revenues, control expenses, raise capital and sustain adequate working capital to finance its operations. The failure to achieve the necessary levels of profitability and cash flows would be detrimental to the Company. The consolidated financial statements do not include any adjustments that may be necessary if the Company is unable to continue as a going concern. Note 4. Related Party Transactions The Company sells products to Brownie’s Southport Divers, Brownie’s Yacht Toys and Brownie’s Palm Beach Divers, companies owned by the brother of Robert Carmichael, the Company’s Chief Executive Officer and Chief Financial Officer. Terms of sale are no more favorable than those extended to any of the Company’s other customers with similar sales volumes. These entities accounted for 7.5 % and 6.7 % of the net revenues for the six months ended June 30, 2026 and June 30, 2025, respectively. Accounts receivable from these entities totalled $ 55,659 and $ 16,984 , at June 30, 2026 and December 31, 2025, respectively. The Company sells products to Brownies Global Logistics (“BGL”) and 940 Associates (“940 A”), entities wholly-owned by Robert Carmichael. Terms of sale are more favorable than those extended to the Company’s regular customers, but no more favorable than those extended to the Company’s strategic partners. Accounts receivable from these entities totalled $ 0 at June 30, 2026 and December 31, 2025. The Company had accounts payable to related parties of $ 25,107 and $ 12,972 at June 30, 2026 and December 31, 2025, respectively. The balance payable at June 30, 2026 was comprised of $ 10,190 due to 940 A, $ 2,125 due to Robert Carmichael, $ 10,000 due to Robert Carmichael from LWA and $ 2,786 due to Blake Carmichael from BLU3. At December 31, 2025, the balance payable was comprised of $ 0 due to 940 A, $ 29,717 due to Robert Carmichael and $ 2,786 due to Blake Carmichael. The Company has exclusive license agreements with 940 A to license the trademark “Brownie’s Third Lung”, “Tankfill”, “Brownie’s Public Safety” and various other related trademarks as listed in the agreements. The agreements provide that the Company pay 2.5 % of gross revenues per quarter as a royalty to 940A. Total royalty fees paid to 940A for the six months ended June 30, 2026 and June 30, 2025 was $ 18,032 and $ 17,393 , respectively. The accrued royalty for June 30, 2026 and December 31, 2025 was $ 8,125 and $ 2,450 , respectively, which is included in other liabilities. On September 30, 2022, the Company issued a convertible demand 8 % promissory note in the principal amount of $ 66,793 to Robert Carmichael for funds to meet the working capital needs of LBI. There is no amortization schedule for the note, and interest is payable in shares of common stock of the Company at a conversion price equal to the 90 day value weighted average price (“VWAP”) of the Company’s stock prior to the quarterly interest payment date. The note holder may demand payment or convert the outstanding principal at a conversion rate of $ 0.021 per share at any time. The conversion rate was calculated at a 35 % discount to the 90 day VWAP of the Company’s stock as of the date of the note. The Company recorded $ 19,250 for the beneficial conversion feature. As this conversion rate is a fixed rate, the embedded conversion feature is not a derivative liability. There were payments totalling $ 34,329 made with products in kind during the quarterly period ended June 30, 2026. The outstanding balance on this note was $ 29,717 as of June 30, 2026. On January 18, 2023 and February 18, 2023, the Company issued to Charles Hyatt, a Company director, an aggregate of 11,428,570 units, with each unit consisting of one share of common stock and a two-year warrant to purchase one share of common stock at an exercise price of $ 0.0175 per share in consideration of $ 200,000 . On September 14, 2023, the Company issued a convertible demand promissory note in the principal amount of $ 50,000 to Robert Carmichael for funds to meet the working capital needs of BLU3. There is no amortization schedule for the note as the note is interest free. The Company recorded $- 0 - for the beneficial conversion feature. As this conversion rate is a fixed rate, the embedded conversion feature is not a derivative liability. The outstanding balance on this note was $ 50,000 as of June 30, 2026. On November 14, 2023, the Company borrowed funds through the issuance of a promissory note in the principal amount of $ 150,000 to Charles Hyatt, a Company director, for working capital requirements and payment of certain expenses in connection with the Company’s business combinations. The balance of $ 150,000 was outstanding as of December 31, 2025, and the maturity date was extended from May 7, 2025 to November 5, 2025 , pursuant to an amendment dated November 13, 2025. The note bears interest at a rate of 9.9 % per annum, and has a default interest of 18 % per annum. Interest payments are due and payable on a monthly basis. The Company may prepay the Note in whole or in part, at any time without premium or penalty. On December 23, 2023, the Company issued a demand promissory note in the principal amount of $ 25,000 to Robert Carmichael for funds to meet the working capital needs of BLU3. There is no amortization schedule for the note as the note is interest free. The Company recorded $ 0 for the beneficial conversion feature. As this conversion rate is a fixed rate, the embedded conversion feature is not a derivative liability. The outstanding balance on this note was $ 25,000 as of June 30, 2026. 13 On February 5, 2025, the Company borrowed funds through the issuance of a promissory note (the Note) in the principal amount of $ 280,000 to Charles Hyatt, a Company director, for working capital requirements and payment of certain expenses in connection with the Company’s business combinations. The balance of $ 280,000 was outstanding as of December 31, 2025, and the maturity date was extended from August 6, 2025 to November 5, 2025 , pursuant to an amendment dated November 13, 2025. The note bears interest at a rate of 9.9 % per annum, and has a default interest of 18 % per annum. Interest payments are due and payable on a monthly basis. The Company may prepay the Note in whole or in part, at any time without premium or penalty. On June 8, 2026, the Company recorded $ 103,043 as interest expense. The interest expense was for a note for $ 280,000 as of February 5, 2025, and a note for $ 150,000 as of November 14, 2023. On March 31, 2023, the Company issued 61,204 shares of common stock to Robert Carmichael for payment of interest on the convertible demand note for the three months ending March 31, 2023. The fair value of these shares was $ 1,336 . On June 30, 2023, the Company issued 61,677 shares of common stock to Robert Carmichael for payment of interest on the convertible demand note for the three months ending June 30, 2023. The fair value of these shares was $ 1,287 . On September 30, 2023, the Company issued 61,677 shares of common stock to Robert Carmichael for payment of interest on the convertible demand note for the three months ending September 30, 2023. The fair value of these shares was $ 1,287 . On December 31, 2023, the Company issued 61,677 shares of common stock to Robert Carmichael for payment of interest on the convertible demand note for the three months ending December 31, 2023. The fair value of these shares was $ 1,287 . On March 31, 2025, the Company issued 61,677 shares of common stock to Robert Carmichael for payment of interest on the convertible demand note for the three months ending March 31, 2025. The fair value of these shares was $ 1,287 . On July 16, 2025, the Company issued 61,677 shares of common stock to Robert Carmichael for payment of interest on the convertible demand note for the three months ending June 30, 2025. The fair value of these shares was $ 1,287 . On December 9, 2025, the Company issued 8,241,759 shares of common stock to Blake Carmichael, the chief executive officer of BLU3, as compensation for a reduction in salary. The fair value of these shares was $ 60,000 . 14 Note 5. Convertible Promissory Notes and Loans Payable Convertible Promissory Notes Convertible promissory notes consisted of the following at June 30, 2026: Schedule of Convertible Debentures Origination Date Maturity Date Interest Rate Origination Principal Balance Original Discount Balance Period End Principal Balance Period End Discount Balance Payments Period End Balance Note 9/03/21 9/03/24 8 % 346,500 ( 12,355 ) $ 346,500 $ 7,550 $ - 354,050 (1) 9/03/21 9/03/24 8 % 3,500 ( 125 ) 3,500 73 - 3,573 (2) 9/30/22 Demand 8 % 66,793 ( 19,250 ) 66,793 ( 19,250 ) ( 17,826 ) 29,717 (3) 9/14/23 Demand 8 % - - 50,000 - ( 5,000 ) 45,000 (4) $ 466,793 $ ( 11,627 ) $ ( 22,826 ) $ 432,340 (1) On September 3, 2021, the Company issued a three-year 8% convertible promissory note in the principal amount of $346,500 to Summit Holding V, LLC as part of the acquisition of SSI. The Company is required to make quarterly payments under the note in an amount equal to 50% of the adjusted net profit of SSI. Interest is payable quarterly in shares of common stock of the Company at a conversion price of $0.051272 per share. The note holder may convert outstanding principal and interest into shares of common stock at a conversion price of $0.051272 per share at any time during the term of the note. The Company recorded $12,355 for the beneficial conversion feature. This note is classified as a current liability for the six months ended June 30, 2026 The maturity due date of the note had been extended by the lender from September 3, 2025. The Company is working with the lender to restructure the note. (2) On September 3, 2021, the Company issued a three-year 8% promissory note in the principal amount of $3,500 to Tierra Vista Partners, LLC as part of the acquisition of SSI. The Company is required to make quarterly payments under the note in an amount equal to 50% of the adjusted net profit of SSI. Interest is payable quarterly in common stock of the Company at a conversion price of $0.051272 per share. The note holder may convert outstanding principal and interest into shares of common stock at a conversion price of $0.051272 at any time during the term of the note. The Company recorded $125 for the beneficial conversion feature. This note is classified as a current liability for the three months ended June 30, 2026 (3) On September 30, 2022, the Company issued a convertible demand 8% promissory note in the principal amount of $66,793 to Robert Carmichael for funds to meet the working capital needs of LBI. There is no amortization schedule for the note and interest is payable in shares of common stock of the Company at a conversion price equal to the 90 day volume weighted average (VWAP) of the Company’s common stock prior to the quarterly interest payment date. This note is classified as a current liability as the note holder may demand payment or convert the outstanding principal at a conversion price of $0.021 per share at any time. The Company recorded $19,250 for the beneficial conversion feature. (4) On September 14, 2023, the Company issued a convertible demand 8% promissory note in the principal amount of $50,000 to Robert Carmichael for working capital needs of BLU3. There is no amortization schedule for the note, and interest is payable in shares of common stock of the Company at a conversion price equal to the 90 day (VWAP) of the Company’s common stock prior to the quarterly interest payment date. The note holder may demand payment or convert the outstanding principal at a conversion rate of $0.01351 per share at any time. The conversion rate was calculated at a 35% discount to the 90 day VWAP of the Company’s stock as of the date of the note. The Company recorded $-0- for the beneficial conversion feature. As this conversion rate is a fixed rate, the embedded conversion feature is not a derivative liability. The outstanding balance on this note was $45,000 as of December 31, 2025 and December 31, 2024. Mr. Carmichael has waived interest payments on this note effective September 14, 2023. Demand Notes On November 14, 2023, the Company issued a promissory note in the principal amount of $150,000 to Charles Hyatt, a director, for working capital requirements and payment of certain expenses in connection with the Company’s business combinations. The Note bears interest at a rate of 9.9% per annum, and has a default interest of 18% per annum. Interest payments are due and payable on a monthly basis. The Company may prepay the Note in whole or in part, at any time without premium or penalty. The balance of $280,000 was outstanding as of December 31, 2025, and the maturity date was extended from May 7, 2025 to November 5, 2025, pursuant to an amendment dated November 13, 2025. On February 5, 2025, the Company borrowed funds through the issuance of a promissory note in the principal amount of $280,000 to Charles Hyatt, a Company director, for working capital requirements and payment of certain expenses in connection with the Company’s business combinations. The note bears interest at a rate of 9.9% per annum, and has a default interest rate of 18% per annum. Interest payments are due and payable on a monthly basis. The Company may prepay the note in whole or in part, at any time without premium or penalty. The balance of $280,000 was outstanding as of December, and the maturity date was extended from August 6, 2025 to November 5, 2025, pursuant to an amendment dated November 13, 2025. A breakdown of current and long-term amounts due are as follows for the convertible promissory notes as of June 30, 2026: Schedule of Breakdown Current and Long-term Amounts Summit Holdings V, LLC Note Tierra Vista Partners, LLC Note Robert Carmichael Note Robert Carmichael BLU3 Note Total (1) (2) (3) (4) 2026 $ 346,500 $ 3,500 $ 66,793 $ 50,000 $ 466,793 Discount and payments 7,550 73 ( 37,076 ) $ ( 5,000 ) $ ( 34,453 ) Total Loan Payments $ 354,050 $ 3,573 $ 29,717 $ 45,000 $ 432,340 Current Portion of Loan Payable $ ( 354,050 ) $ ( 3,573 ) $ ( 29,717 ) $ ( 45,000 ) $ ( 432,340 ) Non-Current Portion of Loan Payable $ - $ - $ - $ - $ - (1) On September 3, 2021, the Company issued a three-year 8 % convertible promissory note in the principal amount of $ 346,500 to Summit Holding V, LLC as part of the acquisition of SSI. The Company is required to make quarterly payments under the note in an amount equal to 50 % of the adjusted net profit of SSI. Interest is payable quarterly in shares of common stock of the Company at a conversion price of $ 0.051272 per share. The note holder may convert outstanding principal and interest into shares of common stock at a conversion price of $ 0.051272 per share at any time during the term of the note. The Company recorded $ 12,355 for the beneficial conversion feature. This note is classified as a current liability for the six months ended June 30, 2026 The maturity due date of the note had been extended by the lender from September 3, 2025. The Company is working with the lender to restructure the note. Schedule of Future Amortization of Notes Payable Payment Amortization 2026 - Total Note Payments $ 346,500 Current portion of note payable ( 346,500 ) Non-Current Portion of Notes Payable $ - (2) On September 3, 2021, the Company issued a three-year 8 % promissory note in the principal amount of $ 3,500 to Tierra Vista Partners, LLC as part of the acquisition of SSI. The Company is required to make quarterly payments under the note in an amount equal to 50 % of the adjusted net profit of SSI. Interest is payable quarterly in common stock of the Company at a conversion price of $ 0.051272 per share. The note holder may convert outstanding principal and interest into shares of common stock at a conversion price of $ 0.051272 at any time during the term of the note. The Company recorded $ 125 for the beneficial conversion feature. This note is classified as a current liability for the six months ended June 30, 2026 The maturity due date of the note had been extended by the lender from September 3, 2025. The Company is working with the lender to restructure the note. Schedule of Future Amortization of Notes Payable Payment Amortization 2026 - Total Note Payments $ 3,500 Current portion of note payable ( 3,500 ) Non-Current Portion of Notes Payable $ - (3) On September 30, 2022, the Company issued a convertible demand 8 % promissory note in the principal amount of $ 66,793 to Robert Carmichael for funds to meet the working capital needs of LBI. There is no amortization schedule for the note and interest is payable in shares of common stock of the Company at a conversion price equal to the 90 day volume weighted average (VWAP) of the Company’s common stock prior to the quarterly interest payment date. This note is classified as a current liability as the note holder may demand payment or convert the outstanding principal at a conversion price of $ 0.021 per share at any time. The Company recorded $ 19,250 for the beneficial conversion feature. (4) On September 14, 2023, the Company issued a convertible demand 8 % promissory note in the principal amount of $ 50,000 to Robert Carmichael for working capital needs of BLU3. There is no amortization schedule for the note, and interest is payable in shares of common stock of the Company at a conversion price equal to the 90 day (VWAP) of the Company’s common stock prior to the quarterly interest payment date. The note holder may demand payment or convert the outstanding principal at a conversion rate of $ 0.01351 per share at any time. The conversion rate was calculated at a 35 % discount to the 90 day VWAP of the Company’s stock as of the date of the note. The Company recorded $- 0 - for the beneficial conversion feature. As this conversion rate is a fixed rate, the embedded conversion feature is not a derivative liability. The outstanding balance on this note was $ 45,000 as of December 31, 2025 and December 31, 2024. Mr. Carmichael has waived interest payments on this note effective September 14, 2023. 15 Demand Notes On November 14, 2023, the Company issued a promissory note in the principal amount of $ 150,000 to Charles Hyatt, a director, for working capital requirements and payment of certain expenses in connection with the Company’s business combinations. The Note bears interest at a rate of 9.9 % per annum, and has a default interest of 18 % per annum. Interest payments are due and payable on a monthly basis. The Company may prepay the Note in whole or in part, at any time without premium or penalty. The balance of $ 280,000 was outstanding as of December 31, 2025, and the maturity date was extended from May 7, 2025 to November 5, 2025 , pursuant to an amendment dated November 13, 2025. On February 5, 2025, the Company borrowed funds through the issuance of a promissory note in the principal amount of $ 280,000 to Charles Hyatt, a Company director, for working capital requirements and payment of certain expenses in connection with the Company’s business combinations. The note bears interest at a rate of 9.9 % per annum, and has a default interest rate of 18 % per annum. Interest payments are due and payable on a monthly basis. The Company may prepay the note in whole or in part, at any time without premium or penalty. The balance of $ 280,000 was outstanding as of December, and the maturity date was extended from August 6, 2025 to November 5, 2025 , pursuant to an amendment dated November 13, 2025. Loans Payable Schedule of Future Amortization of Loans Payable Navitas 2024 BLU3 (5) Navitas 2026 BLU3 (6) Navitas 2026 BTL (7) Bank United 2026 BLU3 (8) Total 2026 $ 3,245 2,873 2,275 $ 2,143 $ 10,536 2027 $ 7,091 6,345 5,002 4,736 $ 23,174 2028 $ 7,977 7,235 5,672 5,387 $ 26,271 Thereafter $ 708 2,631 4,747 8,499 $ 16,585 Total Loan Payments $ 19,022 $ 19,084 $ 17,696 $ 20,766 $ 76,566 Current Portion of Loan Payable $ ( 6,686 ) $ ( 5,941 ) $ ( 4,697 ) $ ( 4,438 ) $ ( 21,762 ) Non-Current Portion of Loan Payable $ 12,335 $ 13,142 $ 12,999 $ 16,328 $ 54,804 (5) On February 12, 2024, BLU3 executed an inventory finance agreement to finance the purchase of certain equipment stock through Navitas. The amount financed is $ 32,274 payable over 60 equal monthly installments of $ 715 . The inventory finance agreement contains customary events of default. The loan balance as of June 30, 2026 was $ 19,022 and $ 28,123 as of December 31, 2025. (6) On June 10, 2026 BLU3 executed an equipment finance agreement to finance the purchase of certain plastic molding equipment through Navitas. The amount financed is $ 20,000 payable over 36 equal monthly instalments of $ 675.87 . The equipment finance agreement contains customary events of default. The loan balance as of June 30, 2026 was $ 19,083.63 . (7) On October 4, 2024, Brownies Third Lung (BTL) an inventory finance agreement to finance the purchase of certain equipment stock through Navitas. The amount financed is $ 24,620.004 payable over 60 equal monthly instalments of $ 602 . The inventory finance agreement contains customary events of default. The loan balance as of June 30, 2026 was $ 17,696 .and $ 19,831 as of December 31, 2025. (8) On March 23, 2026, BLU3 executed an equipment finance agreement with Bank United to purchase a forklift for the warehouse. The installment agreement is for $ 21,450 .to purchase a forklift. The Interest rate is 12.87 %. The monthly installment amount is $ 574.07 for 48 months. The first payment will be due on 05.01.2026. This loan is personally guaranteed by Mr. Carmichael. respectively). Note 6. Goodwill and Intangible Assets, Net The following table sets for the changes in the carrying amount of the Company’s Goodwill for the six months ended June 30,. Summary of Changes in Goodwill 2026 Balance, January 1 $ 249,986 Addition: - Balance, June 30 2026 $ 249,986 The Company performed an evaluation of the value of goodwill at December 31, 2025. Based upon this evaluation it was determined that there should be no adjustment to goodwill. There has been nothing noted during the six months ended June 30, 2026 that would indicate that the value of goodwill should change through that date. The following table sets for the components of the Company’s intangible assets at June 30, 2026: Summary of Intangible Assets Amortization Period (Years) Cost Accumulated Amortization Net Book Value Intangible Assets Subject to amortization Trademarks 15 $ 121,000 $ ( 36,868 ) $ 84,132 Customer Relationships 10 600,000 ( 280,000 ) 320,000 Non-Compete Agreements 5 22,000 ( 21,266 ) 734 Total $ 743,000 $ ( 3338,134 ) $ 404,866 16 The aggregate amortization remaining on the intangible assets as of June 30, 2026 is a follows: Schedule of Estimated Intangible Assets Amortization Expenses Intangible Assets Amortization 2026 (6 months remaining) $ 35,133 2027 68,067 2028 68,067 2029 68,067 Thereafter 98,800 Total $ 338,133 Amortization expense for amortizable intangible assets for each of the six months ended June 30, 2026 and 2025 was $ 36,233 . Note 7. Stockholders’ Equity Common Stock On January 18, 2023 and February 18, 2023, the Company issued to Charles Hyatt, an aggregate of 11,428,570 units, with each unit consisting of one share of common stock and a two-year warrant to purchase one share of common stock at an exercise price of $ 0.0175 per share in consideration of $ 200,000 . On March 31, 2023, the Company issued 61,204 shares of common stock to Robert Carmichael for payment of interest on the convertible demand note for the three months ending March 31, 2023. The fair value of these shares was $ 1,336 . On March 31, 2023, the Company issued an aggregate of 137,000 shares of common stock to the holders of convertible notes for payment of interest for the three months ending December 31, 2022. The fair value of these shares was $ 7,000 . On June 30, 2023, the Company issued 61,205 shares of common stock to Robert Carmichael for payment of interest on the convertible demand note for the three months ending June 30, 2023. The fair value of these shares was $ 1,326 . On June 30, 2023, the Company issued an aggregate of 137,000 shares of common stock to the holders of convertible notes for payment of interest for the three months ending June 30, 2023. The fair value of these shares was $ 7,000 . On September 30, 2023, the Company issued 61,205 shares of common stock to Robert Carmichael for payment of interest on the convertible demand note for the three months ending September 30, 2023. The fair value of these shares was $ 1,326 . On September 30, 2023, the Company issued an aggregate of 137,000 shares of common stock to the holders of convertible notes for payment of interest for the three months ending September 30, 2023. The fair value of these shares was $ 7,000 . On December 31, 2023, the Company issued 61,677 shares of common stock to Robert Carmichael for payment of interest on the convertible demand note for the three months ending December 31, 2023. The fair value of these shares was $ 1,287 . On December 31, 2023, the Company issued an aggregate of 136,527 shares of common stock to the holders of convertible notes for payment of interest for the three months ending December 31, 2023. The fair value of these shares was $ 7,000 . On March 31, 2025, the Company issued 61,677 shares of common stock to Robert Carmichael for payment of interest on the convertible demand note for the three months ending March 31, 2025. The fair value of these shares was $ 4,007 . On March 31, 2025, the Company issued an aggregate of 136,527 shares of common stock to the holders of convertible notes for payment of interest for the three months ending March 31, 2025. The fair value of these shares was $ 7,000 . On June 30, 2025, the Company issued 123,354 shares of common stock to Robert Carmichael for payment of interest on the convertible demand note for the three months ending June 30, 2025. The fair value of these shares was $ 2,672 . On June 30, 2025, the Company issued an aggregate of 136,527 shares of common stock to the holders of convertible notes for payment of interest for the three months ending June 30, 2025. The fair value of these shares was $ 7,000 . On August 15, 2025 the Company issued 850,000 shares of common stock to the holders of convertible notes for payment of professional services. The fair market value of these shares was $ 8,500 . On March 31, 2025, the Company issued an aggregate of 136,527 shares of common stock to the holders of convertible notes for payment of interest for the three months ending March 31, 2025. The fair value of these shares was $ 7,000 . 17 On December 9, 2025, the Company issued 8,241,759 shares to Blake Carmichael as compensation related to a salary reduction. The fair market value of these shares was $ 60,000 . On December 31, 2025, the Company issued an aggregate of 136,527 shares of common stock to the holders of convertible notes for payment of interest for the three months ending December 31, 2025. The fair value of these shares was $ 7,000 . On March 31, 2025, the Company issued an aggregate of 136,527 shares of common stock to the holders of convertible notes for payment of interest for the three months ending March 31 2025. The fair value of these shares was $ 7,000 . On June 30, 2025, the Company issued an aggregate of 136,527 shares of common stock to the holders of convertible notes for payment of interest for the three months ending June 30, 2025. The fair value of these shares was $ 7,000 . On August 31, 2025, the Company issued an aggregate of 3,302,148 shares of common stock to Blake Carmichael as compensation for cash reduction in his salary. The fair value of these shares was $ 22,667 . On September 30, 2025, the Company issued an aggregate of 351,958 shares of common stock to Blake Carmichael as compensation for cash reduction in his salary. The fair value of these shares was $ 2,833 . On September 30, 2025, the Company issued an aggregate of 136,527 shares of common stock to the holders of convertible notes for payment of interest for the three months ending September 30, 2025. The fair value of these shares was $ 7,000 . On December 31, 2025, the Company issued an aggregate of 136,527 shares of common stock to the holders of convertible notes for payment of interest for the three months ending December 31, 2025. The fair value of these shares was $ 7,000 . On December 31, 2025, the Company issued an aggregate of 216,093 shares of common stock to Blake Carmichael as compensation for cash reduction in his salary. The fair value of these shares was $ 2,833 . On January 31, 2026, the Company issued an aggregate of 440,188 shares of common stock to Blake Carmichael as compensation for cash reduction in his salary. The fair value of these shares was $ 2,833 . On February 28, 2026, the Company issued an aggregate of 509,704 shares of common stock to Blake Carmichael as compensation for cash reduction in his salary. The fair value of these shares was $ 2,833 . On March 31, 2026, the Company issued an aggregate of 640,152 shares of common stock to Blake Carmichael as compensation for cash reduction in his salary. The fair value of these shares was $ 2,833 . On March 31, 2026, the Company issued an aggregate of 136,527 shares of common stock to the holder of convertible note for payment of interest for the three months ending March 31, 2026. The fair value of these shares was $ 7,000 . On April 30, 2026, the Company issued an aggregate of 466,800 shares of common stock to Blake Carmichael as compensation for cash reduction in his salary. The fair value of these shares was $ 2,833 . On May 1, 2026, the Company issued an aggregate of 1,562,500 shares of common stock to an employee as a signing bonus. The fair value of these shares was $ 10,000 . On May 31, 2026, the Company issued an aggregate of 451,245 shares of common stock to Blake Carmichael as compensation for cash reduction in his salary. The fair value of these shares was $ 2,833 . On June 10, 2026, the Company issued an aggregate of 250,000 shares of common stock to Robert Carmichael for compensation for board of directors’ fees for December 2025. The fair value of these shares was $ 1,500 . On June 10, 2026, the Company issued an aggregate of 250,000 shares of common stock to Chrles F. Hyatt for compensation for board of directors’ fees for December 2025. The fair value of these shares was $ 1,500 . On June 10, 2026, the Company issued an aggregate of 1,097,561 shares of common stock to Robert Carmichael for compensation for board of directors’ fees for the first quarter ended March 31, 2026. The fair value of these shares was $ 4,500 . 18 On June 10, 2026, the Company issued an aggregate of 1,097,561 shares of common stock to Charles F. Hyatt for compensation for board of directors’ fees for the quarter ended March 31, 2026. The fair value of these shares was $ 4,500 . On June 30, 2026, the Company issued an aggregate of 1,022,727 shares of common stock to Charles F. Hyatt for compensation for board of directors’ fees for quarter June 30, 2026. The fair value of these shares was $ 4,500 . On June 30, 2026, the Company issued an aggregate of 1,097,561 shares of common stock to Robert Carmichael for compensation for board of directors’ fees for quarter ended March 31, 2026. The fair value of these shares was $ 4,500 . On June 30, 2026, the Company issued an aggregate of 515,857 shares of common stock to Blake Carmichael as compensation for cash reduction in his salary. The fair value of these shares was $ 2,833 . On June 30, 2026, the Company issued an aggregate of 136,527 shares of common stock to the holder of a convertible note for payment of interest for the three months ended June 30, 2026. The fair value of these shares was $ 7,000 Preferred Stock During the second quarter of 2010, the holders of the majority of the Company’s outstanding shares of common stock approved an amendment to the Company’s Articles of Incorporation authorizing the issuance of 10,000,000 shares of blank check preferred stock. The blank check preferred stock as authorized has such voting powers, designations, preferences, limitations, restrictions and relative rights as may be determined by the Board of Directors of the Company from time to time in accordance with the provisions of the Florida Business Corporation Act. In April 2011, the Board of Directors designated 425,000 shares as Series A Convertible Preferred Stock. Each share of Series A Convertible Preferred Stock is convertible into a share of the Company’s common stock at any time at the option of the holder at a conversion price of $ 18.23 per share. Holders of shares of Series A Convertible Preferred Stock are entitled to 250 votes for each share held. The Company’s common stock and Series A Convertible Preferred Stock vote together on any matters submitted to our shareholders. As of June 30, 2026, and December 31, 2025, 425,000 shares of Series A Convertible Preferred Stock are issued and outstanding and are owned by Robert Carmichael. Equity Incentive Plan On May 26, 2021 the Company adopted an Equity Incentive Plan (the “Plan”). Under the Plan, stock options may be granted to employees, directors, and consultants in the form of incentive stock options or non-qualified stock options, stock purchase rights, time vested and/performance invested restricted stock, and stock appreciation rights and unrestricted shares may also be granted under the Plan. 25,000,000 shares are reserved for issuance under the Plan. The term of the Plan is ten years. The Company also issued options outside of the Plan that were not approved by the security holders. These options may be granted to employees, directors, and consultants in the form of incentive stock options or non-qualified stock options. Equity Compensation Plan Information as of June 30, 2026 Schedule of Equity Compensation Plan Information Number of securities to be issued upon exercise of outstanding options, warrants and rights (a) Weighted – average exercise price of outstanding options, warrants and rights (b) Number of securities remaining available for future issuances under equity compensation plans (excluding securities reflected in column (a) Equity Compensation Plans Approved by Security Holders 3,150,000 $ 0.0399 21,680,882 Equity Compensation Plans Not Approved by Security Holders 37,801,503 0.0195 — Total 40,951,503 $ 0.0297 21,680,882 19 Options The Company has issued options to purchase approximately 67,314,637 shares of its common stock at an weighted average exercise price of $ 0.0298 with a fair value of approximately $ 37,000 . For the six months ended June 30, 2026, and the year ended December 31, 2025, the Company issued no options to purchase shares. For the three months ended June 30, 2026 and 2025, the Company recognized an expense of $ 0 of non-cash compensation expense (included in General and Administrative expense in the accompanying Consolidated Statement of Operations) determined by application of a Black-Scholes option pricing model with the following inputs: exercise price, dividend yields, risk-free interest rate, and expected annual volatility. As of June 30, 2026, the Company had $ 32,500 of unrecognized pre-tax non-cash compensation expense related to performance based options to purchase shares, which the Company expects to recognize, based on a weighted-average period of . 12 years. The Company uses straight-line amortization of compensation expense over the requisite service period for time-based options. For performance-based options the Company evaluates the likelihood of a vesting qualification being met, and will establish the expense based on that evaluation. The maximum contractual term of the Company’s stock options is 5 years. The Company recognizes forfeitures and expirations as they occur. Options to purchase 37,801,503 shares of common stock have vested as of June 30, 2026. The Company uses the Black-Scholes option-pricing model to estimate the fair value of its stock option awards and warrant issuances. The calculation of the fair value of the awards using the Black-Scholes option-pricing model is affected by the Company’s stock price on the date of grant as well as assumptions regarding the following: Schedule of Valuation Assumptions of Options Six Months ended June 30, 2026 2025 Expected volatility 172.0 % - 346.4 % 172.0 – 346.4 % Expected term . 5 – 4 . Years 1.5 – 5.0 Years Risk-free interest rate 0.16 % - 4.64 % 0.16 % - 4.64 % Forfeiture rate 0.17 % 0.17 % The expected volatility was determined with reference to the historical volatility of the Company’s common stock. The Company uses historical data to estimate option exercise and employee termination within the valuation model. The expected term of options granted represents the period of time that options granted are expected to be outstanding. The risk-free interest rate for periods within the contractual life of the option is based on the U.S. Treasury rate in effect at the time of grant. A summary of the status of the Company’s outstanding stock options as of June 30, 2026 and December 31, 2025 and changes during the periods ending on such dates is as follows: Schedule of Outstanding Stock Option Activity Number of Weighted Average Exercise Weighted Average Remaining Contractual Aggregate Intrinsic Options Price Life in Years Value Outstanding at December 31, 2025 238,439,167 $ 0.0362 1.43 Granted - - Forfeited ( 170,999,530 ) 0.0379 Exercised - - Cancelled - Outstanding – December 31, 2025 67,439,637 $ 0.0360 1.43 Exercisable – December 31, 2025 41,057,753 $ 0.0211 1.33 $ 0 Granted - - Forfeited ( 1,475,000 ) 0.0379 Exercised - - Expired ( 35,295,237 ) Cancelled - - Outstanding – June 30, 2026 30,669,400 $ 0.043268 1.07 Exercisable –June 30, 2026 7,059,400 $ 0.0531 1.106 $ 0 20 The following table summarizes information about employee stock options outstanding at June 30, 2026. Schedule of Exercise Price of Employee Stock Options Outstanding Range of Exercise Price Number outstanding at June 30, 2026 Weighted average remaining Life Weighted average exercise price Number exercisable at June 30, 2026 Weighted average exercise price Weighted average remaining life $ 0.0180 - $ 0.0225 (Expired) 0 0.00 $ 0.0180 0.00 $ 0.0180 0.00 $ 0.0229 - $ 0.0325 50,000 0.12 $ 0.0302 50,000 $ 0.0302 0.12 $ 0.0360 - $ 0.0425 22,109,400 0.09 $ 0.0398 4,409,400 $ 0.0395 0.08 $ 0.0440 - $ 0.0531 7,460,000 0.17 $ 0.0531 1,800,000 $ 0.0530 0.18 Outstanding options 29,619,400 0.11 $ 0.0432 5,959,400 $ 0.0439 0.11 At June 30, 2026, there was $ 7,059,400 of unrecognized stock option expense which may be recognized only if the full vesting requirements for these options are met. At June 30, 2026, there was $ 5,959,400 of total unrecognized stock option expense, which is expected to be recognized on a straight-line basis over a weighted-average period of .11 years . Warrants On January 18, 2023 and February 18, 2023, the Company issued to Charles Hyatt, an aggregate of 11,428,570 units, with each unit consisting of one share of common stock and a two-year common stock purchase warrant to purchase one share of common stock at an exercise price of $ 0.0175 per share in consideration of $ 200,000 . A summary of the Company’s warrants as of December 31, 2025 and changes during the six months ended June 30, 2026 is presented below: Schedule of Warrant Activity Number of Weighted Average Exercise Weighted Average Remaining Contractual Aggregate Intrinsic Warrants Price Life in Years Value Outstanding – December 31, 2025 25,684,521 $ 0.0247 0.93 $ 24,000 Granted - - - - Exercised - Forfeited or Expired 25,684,521 0.0247 0.93 24,000 Outstanding – June 30, 2026 0 $ 0 0 0 Exercisable – June 30, 2026 0 $ 0 0 $ 0 Note 8. Commitments and contingencies Royalty Agreement On June 30, 2020, the Company entered into On June 30, 2020, the Company entered into Amendment No. 2 to its Patent License Agreement with Setaysha Technical Solutions, LLC (“STS”). The amendment set certain limits and expectations of the assistance from STS related to designing and commercializing certain diving products and revised the royalty payments due to STS as consideration for uncompensated services. The Company is obligated to pay STS a minimum yearly royalty of $ 60,000 , or$ 15,000 per fiscal quarter, beginning in December 2019 and increasing by 2.15 % per year. The minimum royalty was temporarily increased to $ 60,000 for fiscal years 2022, 2023 and 2025, with a fourth quarter true up against earned royalties. In addition, if the Company terminates the Agreement with STS prior to December 31, 2023, the Company is obligated to pay STS $ 180,000 , less cumulative royalties paid in excess of $ 200,174 for the years 2019 through 2025. In accordance with the amendment, the Company will pay additional minimum royalties of $ 60,000 per year or $ 15,000 per quarter for the years 2022 through 2025. On January 24, 2025, the Company entered into Addendum No. 3 to the STS Agreement. Addendum No. 3 delays the additional minimum yearly royalty of $ 60,000 , or $ 15,000 per fiscal quarter from 2025 to 2025. Therefore, no additional minimum royalty was required during 2025, but will be required beginning the fiscal first quarter of 2025. 2025 will be the final year of the additional minimum royalty under the STS agreement. On November 1, 2022 the Company issued 1,155,881 shares of common stock with a fair value of $ 30,000 to the designers of STS in accordance with the Patent License Agreement. Royalty recorded under the Amended agreement was $ 125,159.32 and $ 138,643 for the years ended December 31, 2025 and 2024, respectively. As included in other liabilities, accrued royalties under this agreement were $ 35,020 and $ 41,151 at December 31, 2026 and 2025. 21 Consulting and Employment Agreements On August 1, 2021, the Company and Blake Carmichael entered into a three-year employment agreement (the “Blake Carmichael Employment Agreement”) pursuant to which Mr. Carmichael served as Chief Executive Officer of BLU3. In consideration for his services, Blake Carmichael received (i) an annual base salary of $ 120,000 , payable in accordance with the customary payroll practices of the Company, (ii) a cash bonus equal to 5% of the net income of BLU3, payable quarterly, beginning with the first full calendar quarter after the execution of the agreement, and (iii) upon execution of the Carmichael Employment Agreement, a non-qualified five-year stock option to purchase 3,759,400 shares at $ 0.0399 , 33.3% of which shares vest immediately, 33.3% vest on the second anniversary, and 33.3% vest on the third anniversary of the agreement. In addition, Blake Carmichael is entitled to receive a five-year 5 stock option to purchase up to 18,000,000 shares of common stock at an exercise price of $ 0.0399 per share that will vest upon annual financial metrics based upon a revenue measurement, expediency measurement and an EBITDA measurement. A measurement was made for the six months ended June 30, 2026 resulting in no additional expense since the vesting criteria were not met. On September 3, 2021, SSI and Christeen Buban entered into a three-year employment agreement (the “Buban Employment Agreement”) pursuant to which Ms. Buban shall serve as the President of SSI. In consideration for her services, Mrs. Buban shall receive (i) an annual base salary of $ 110,000 , payable in accordance with the customary payroll practices of the Company, (ii) a car allowance and cell phone allowance of $ 10,800 per year, (iii) a five-year 5 option issued under the Plan to purchase 300,000 shares of common stock of the Company at $ 0.0531 per share, which option vests quarterly over the eight calendar quarters. In addition, Mrs. Buban is entitled to receive a five-year 5 stock option to purchase up to 7,110,000 shares of common stock of the Company at an exercise price of $ 0.0531 per share, which vests upon the attainment of certain defined annual financial metrics, as set forth in the Buban Employment Agreement. A measurement was made for the three months ended March 31, 2026 and no expense was recorded based upon the vesting criteria not being met. On January 17, 2022, the Company entered into an agreement with The Crone Law Group, PC (“CLG”) for the provision of legal services. In consideration therefore, the Company will pay CLG a monthly flat fee of $ 3,000 for SEC reporting work and its normal hourly rate for other legal work and issued 1,000,000 shares of common stock with a fair market value of $ 27,500 to CLG. On May 2, 2022, the Company entered into a two-year employment agreement with Steven Gagas (the “Gagas Employment Agreement”) pursuant to which Mr. Gagas shall serve as the General Manager of the dive shop currently operating within LBI. In consideration for his services Mr. Gagas shall receive an annual salary of $ 50,000 . On May 2, 2022, LBI, entered into a lease assignment agreement with Gold Coast Scuba, LLC and Vicnsons Realty Group, LLC whereby LBI is the assignee of a three year lease for the property located at 259 Commercial Blvd., Suites 2 and 3 in Lauderdale-By-The Sea, Florida for $ 2,816 per month base rent. The lease expired on March 31, 2023 and LBI is currently renting on a month to month basis. LBI has the option to renew the lease for a two year term with an increase of base rent of 3.5 %. On September 14, 2022, SSI entered into a sixty-month lease renewal for its facility in Huntington Beach, California commencing on February 1, 2022 with base rent of approximately $ 17,550 per month for the first 24 months with an annual escalation clause of 3.0 % thereafter. Obligations under the lease are guaranteed by the Company. The Company paid an additional security deposit of $ 10,727 upon entering into the lease. On September 30, 2022, SSI entered into a sublease of its facility in Huntington Beach, California with Camburg Engineering, Inc. (“Tenant”) commencing October 1, 2022, The term of the sublease is through December 31, 2023, with a base monthly rent of $ 2,247 for the first twelve months with a 3 % annual escalation thereafter. The Tenant also pays a monthly common area maintenance of $ 112 . The Tenant provided a security deposit of $ 2,426 upon entering into the sublease. On December 22, 2022, the U.S. Consumer Products Safety Commission (the “CPSC”) issued a voluntary recall notice for the Nomad tankless dive system, which is distributed by BLU3, Inc. As part of the recall procedure, the CPSC has approved the Company’s proposed remedy for the recall and BLU3 received units back from consumers to repair affected Nomad units. The Company has evaluated the costs of this recall and has deemed it necessary to set an allowance of $ 160,500 for such costs. During the twelve months ended December 31, 2023 the Company repaired and returned 653 units to customers resulting in a reduction of the allowance of $ 93,161 for the twelve months ended December 31, 2023. Legal There were no outstanding legal issues as of June 30, 2026. Note 9. Subsequent Events On July 1, 2026, the Company executed and consummated the transactions contemplated by an asset purchase agreement (the “Asset Purchase Agreement”) by and among Sunrise Paddleboards LLC, a Florida limited liability company (“Sunrise Paddleboards”), Brian Galton, the sole member of Sunrise Paddleboards (the “LLC Member”), the Company and LBI. Pursuant to the terms of the Asset Purchase Agreement, LBI acquired substantially all of Sunrise Paddleboards’ assets and assumed certain liabilities of the business associated with these assets. Sunrise Paddleboards is in the business of providing paddleboarding and kayaking experiences, including paddleboard rental, tour, retail and training. In consideration for the assets purchased, the Company issued 41,000,000 shares of its common stock to the LLC Member and in connection with the acquisition, 2,000,000 shares to an employee of Sunrise Paddleboards, each at a price of $ 0.0044 per share, based upon the closing price of the Company’s common stock on the OTC Markets on June 30, 2026. On November 20, 2025, the “Company, and Charles Hyatt, a director of the Company (“Hyatt”), executed (a) a third amendment to a promissory note in the principal amount of $ 150,000 , which was originally issued by the Company to Hyatt on November 7, 2023 (the “2023 Note”), to further extend the 2023 Note’s maturity date from November 7, 2025 to May 7, 2026 , and (b) a third amendment to a promissory note in the principal amount of $ 280,000 , which was originally issued by the Company to Hyatt on February 5, 2024 (the “2024 Note”), to further extend the 2024 Note’s maturity date from November 5, 2025 to May 5, 2026 . The Company is in discussions with Mr. Hyatt regarding the further extensions of these Notes. The Company has not received any notice of default under the Notes. Effective August 1, 2026, the Company entered into a seven-year lease with Orangemen Holdings, Inc., a Florida corporation, for 20,728 square feet of office and warehouse space in Davie, Florida. Monthly base rent under the lease is approximately $ 38,001 , $ 39,141 , $ 40,316 , 41,525 , 42,771 , $ 44,054 and $ 45,376 from year one through the term of the lease. The Company will also be responsible for its pro rata share of certain operating expenses. 22